We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+9.56%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$812M
AUM Growth
+$219M
Cap. Flow
+$173M
Cap. Flow %
21.28%
Top 10 Hldgs %
42.3%
Holding
3,095
New
215
Increased
1,249
Reduced
951
Closed
267

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$9.74M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$8.67M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.37M
4
AAPL icon
Apple
AAPL
+$6.37M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$5.44M

Top Sells

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$1.33M
2
MGI
MoneyGram International, Inc. New
MGI
+$1.19M
3
IWD icon
iShares Russell 1000 Value ETF
IWD
+$774K
4
FLG
Flagstar Bank National Association
FLG
+$531K
5
EFA icon
iShares MSCI EAFE ETF
EFA
+$438K

Sector Composition

Rank Sector Weight
1 Financials 17.72%
2 Technology 11.11%
3 Healthcare 9.24%
4 Industrials 3.53%
5 Consumer Staples 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANDE icon
2351
Andersons Inc
ANDE
$2.22B
$1.5K ﹤0.01%
43
– –
DUOL icon
2352
Duolingo
DUOL
$6.12B
$1.49K ﹤0.01%
21
+18
+600% +$1.41K
MBUU icon
2353
Malibu Boats
MBUU
$567M
$1.49K ﹤0.01%
28
+17
+155% +$912
PFBC icon
2354
Preferred Bank
PFBC
$1.25B
$1.49K ﹤0.01%
20
– –
PLMR icon
2355
Palomar
PLMR
$3.45B
$1.49K ﹤0.01%
33
+12
+57% +$818
ITOS
2356
DELISTED
iTeos Therapeutics
ITOS
$1.48K ﹤0.01%
+76
New +$1.49K
TBPH icon
2357
Theravance Biopharma
TBPH
$877M
$1.48K ﹤0.01%
132
+99
+300% +$1.04K
DHIL
2358
DELISTED
Diamond Hill
DHIL
$1.48K ﹤0.01%
8
+5
+167% +$887
CRC icon
2359
California Resources
CRC
$4.62B
$1.48K ﹤0.01%
+34
New +$1.49K
AVIR icon
2360
Atea Pharmaceuticals
AVIR
$420M
$1.48K ﹤0.01%
307
+18
+6% +$91
IMGN
2361
DELISTED
Immunogen Inc
IMGN
$1.47K ﹤0.01%
297
+239
+412% +$1.3K
TVRD
2362
Tvardi Therapeutics
TVRD
$23.4M
$1.47K ﹤0.01%
+4
New +$1.52K
HRTX icon
2363
Heron Therapeutics
HRTX
$92.9M
$1.47K ﹤0.01%
588
+519
+752% +$1.67K
KRC icon
2364
Kilroy Realty
KRC
$4.42B
$1.47K ﹤0.01%
38
-140
-79% -$5.76K
ACAD icon
2365
Acadia Pharmaceuticals
ACAD
$5.03B
$1.47K ﹤0.01%
92
-304
-77% -$4.75K
AQUA
2366
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$1.47K ﹤0.01%
37
-113
-75% -$4.44K
MDU icon
2367
MDU Resources
MDU
$4.32B
$1.46K ﹤0.01%
126
– –
SABR icon
2368
Sabre
SABR
$835M
$1.45K ﹤0.01%
235
-208
-47% -$1.16K
EQX icon
2369
Equinox Gold
EQX
$13.5B
$1.44K ﹤0.01%
439
-2,783
-86% -$9.6K
EWTX icon
2370
Edgewise Therapeutics
EWTX
$4.73B
$1.44K ﹤0.01%
161
+25
+18% +$234
CMAX
2371
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$1.43K ﹤0.01%
13
+6
+86% +$897
LQDA icon
2372
Liquidia Corp
LQDA
$8.02B
$1.43K ﹤0.01%
225
-22
-9% -$118
MTW icon
2373
Manitowoc
MTW
$675M
$1.43K ﹤0.01%
156
+153
+5,100% +$1.4K
ALG icon
2374
Alamo Group
ALG
$2.05B
$1.42K ﹤0.01%
10
+5
+100% +$724
STEM icon
2375
Stem
STEM
$52.7M
$1.4K ﹤0.01%
+8
New +$1.92K
93 94
95
96 97

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Lindbrook Capital held 3,095 positions worth $812M, up 37% from $593M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Lindbrook Capital deployed $173M of net new capital in Q4 2022, opening 215 new positions and adding to 1,249 existing holdings. Its largest new stake was Invesco DB Commodity Index Tracking Fund: 184,095 shares worth $4.54M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $1.33M trimmed.

  • Lindbrook Capital's largest Q4 2022 buy was Invesco DB Commodity Index Tracking Fund: 184,095 shares worth $4.54M.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q4 2022, an estimated $9.74M increase.
  • Lindbrook Capital's biggest Q4 2022 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.33M.
  • Lindbrook Capital fully exited iShares ESG Aware MSCI USA ETF in Q4 2022, selling an estimated $215K.
  • Lindbrook Capital's ten largest holdings make up 42% of its $812M portfolio in Q4 2022.
  • Lindbrook Capital opened 215 new positions and closed 267 in Q4 2022.
  • Lindbrook Capital's portfolio value rose 37% quarter-over-quarter to $812M.

Based on Lindbrook Capital's 13F filing for Q4 2022, filed 25 Jan 2023.